Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Incidence, determinants and consequences of delirium in older patients after transcatheter aortic valve implantation.

Goudzwaard JA, de Ronde-Tillmans MJAG, de Jager TAJ, Lenzen MJ, Nuis RJ, van Mieghem NM, Daemen J, de Jaegere PPT, Mattace-Raso FUS.

Age Ageing. 2020 Feb 24. pii: afaa001. doi: 10.1093/ageing/afaa001. [Epub ahead of print]

PMID:
32091096
2.

Impact of Valvulo-Arterial Impedance on Long-Term Quality of Life and Exercise Performance After Transcatheter Aortic Valve Replacement.

Nuis RJ, Goudzwaard JA, de Ronde-Tillmans MJAG, Kroon H, Ooms JF, van Wiechen MP, Geleijnse ML, Zijlstra F, Daemen J, Van Mieghem NM, Mattace-Raso FUS, Lenzen MJ, de Jaegere PPT.

Circ Cardiovasc Interv. 2020 Jan;13(1):e008372. doi: 10.1161/CIRCINTERVENTIONS.119.008372. Epub 2020 Jan 15.

PMID:
31937136
3.

TAVI Care and Cure, the Rotterdam multidisciplinary program for patients undergoing transcatheter aortic valve implantation: Design and rationale.

De Ronde-Tillmans MJAG, Goudzwaard JA, El Faquir N, van Mieghem NM, Mattace-Raso FUS, Cummins PA, Lenzen MJ, de Jaegere PPT.

Int J Cardiol. 2020 Mar 1;302:36-41. doi: 10.1016/j.ijcard.2019.12.005. Epub 2019 Dec 16.

PMID:
31859111
4.

A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure : Design and rationale of the MONITOR HF multicentre randomised clinical trial.

Brugts JJ, Veenis JF, Radhoe SP, Linssen GCM, van Gent M, Borleffs CJW, van Ramshorst J, van Pol P, Tukkie R, Spee RF, Emans ME, Kok W, van Halm V, Handoko L, Beeres SLMA, Post MC, Boersma E, Lenzen MJ, Manintveld OC, Koffijberg H, van Baal P, Versteegh M, Smilde TD, van Heerebeek L, Rienstra M, Mosterd A, Delnoy PPH, Asselbergs FW, Brunner-La Rocca HP, de Boer RA.

Neth Heart J. 2020 Jan;28(1):16-26. doi: 10.1007/s12471-019-01341-9.

5.

Identifying high-risk patients prior to an Interventional Coronary Procedure; the ongoing search for refining adequate risk-stratification.

Cummins P, van Mieghem NM, Lenzen MJ.

Int J Cardiol. 2020 Jan 15;299:108-109. doi: 10.1016/j.ijcard.2019.08.056. Epub 2019 Aug 30. No abstract available.

PMID:
31493912
6.

Short-term changes of blood pressure and aortic stiffness in older patients after transcatheter aortic valve implantation.

Goudzwaard JA, Disegna E, de Ronde-Tillmans MJ, Lenzen MJ, de Jaegere PP, Mattace-Raso FU.

Clin Interv Aging. 2019 Aug 2;14:1379-1386. doi: 10.2147/CIA.S211328. eCollection 2019.

7.

Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial.

den Uil CA, Van Mieghem NM, B Bastos M, Jewbali LS, Lenzen MJ, Engstrom AE, Bunge JJH, Brugts JJ, Manintveld OC, Daemen J, Wilschut JM, Zijlstra F, Constantinescu AA.

EuroIntervention. 2019 Sep 20;15(7):586-593. doi: 10.4244/EIJ-D-19-00254.

8.

Fractional flow reserve guided percutaneous coronary intervention optimization directed by high-definition intravascular ultrasound versus standard of care: Rationale and study design of the prospective randomized FFR-REACT trial.

van Zandvoort LJC, Masdjedi K, Tovar Forero MN, Lenzen MJ, Ligthart J, Diletti R, Lemmert ME, Wilschut J, de Jaegere PPT, Zijlstra F, van Mieghem NM, Daemen J.

Am Heart J. 2019 Jul;213:66-72. doi: 10.1016/j.ahj.2019.03.017. Epub 2019 Apr 10.

PMID:
31128504
9.

Association between cardiovascular disease and a history of cancer in patients with chest pain on the fast track outpatient clinic.

Sharma SP, Lenzen MJ, Galema TW, Manintveld OC.

Neth Heart J. 2019 Jul;27(7-8):362-370. doi: 10.1007/s12471-019-1268-8.

10.

Design and rationale of haemodynamic guidance with CardioMEMS in patients with a left ventricular assist device: the HEMO-VAD pilot study.

Veenis JF, Manintveld OC, Constantinescu AA, Caliskan K, Birim O, Bekkers JA, van Mieghem NM, den Uil CA, Boersma E, Lenzen MJ, Zijlstra F, Abraham WT, Adamson PB, Brugts JJ.

ESC Heart Fail. 2019 Feb;6(1):194-201. doi: 10.1002/ehf2.12392. Epub 2019 Jan 7.

11.

The Erasmus Frailty Score is associated with delirium and 1-year mortality after Transcatheter Aortic Valve Implantation in older patients. The TAVI Care & Cure program.

Goudzwaard JA, de Ronde-Tillmans MJAG, El Faquir N, Acar F, Van Mieghem NM, Lenzen MJ, de Jaegere PPT, Mattace-Raso FUS.

Int J Cardiol. 2019 Feb 1;276:48-52. doi: 10.1016/j.ijcard.2018.10.093. Epub 2018 Oct 28.

PMID:
30409734
12.

In-hospital cardiovascular events after liver transplantation: predictors and long-term outcome.

Scholte NTB, Lenzen MJ, van der Hoven B, Rietdijk WJR, Metselaar HJ, den Uil CA.

Neth Heart J. 2018 Oct;26(10):506-511. doi: 10.1007/s12471-018-1144-y.

13.

Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation.

De Heide J, Vroegh CJ, Bhagwandien RE, Wijchers SA, Szili-Torok T, Zijlstra F, Lenzen MJ, Yap SC.

J Interv Card Electrophysiol. 2018 Dec;53(3):341-346. doi: 10.1007/s10840-018-0417-0. Epub 2018 Aug 3.

14.

Long-term follow-up of quality of life in high-risk patients undergoing transcatheter aortic valve implantation for symptomatic aortic valve stenosis.

De Ronde-Tillmans MJ, de Jager TA, Goudzwaard JA, El Faquir N, van Mieghem NM, Zijlstra F, Utens EM, Mattace-Raso FU, Lenzen MJ, de Jaegere PP.

J Geriatr Cardiol. 2018 Apr;15(4):261-267. doi: 10.11909/j.issn.1671-5411.2018.04.003.

15.

Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology.

Snaterse M, Deckers JW, Lenzen MJ, Jorstad HT, De Bacquer D, Peters RJG, Jennings C, Kotseva K, Scholte Op Reimer WJM; EUROASPIRE Investigators.

Int J Cardiol. 2018 May 1;258:1-6. doi: 10.1016/j.ijcard.2018.01.064.

16.

[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P.

Kardiol Pol. 2018;76(2):229-313. doi: 10.5603/KP.2018.0041. Polish. No abstract available.

17.

Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy.

Galema-Boers AM, Lenzen MJ, Engelkes SR, Sijbrands EJ, Roeters van Lennep JE.

J Clin Lipidol. 2018 Mar - Apr;12(2):409-416. doi: 10.1016/j.jacl.2017.12.014. Epub 2018 Jan 2.

PMID:
29398430
18.

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Ibánez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P.

Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1082. doi: 10.1016/j.rec.2017.11.010. English, Spanish. No abstract available.

PMID:
29198432
19.

Predictive value of depression and anxiety for long-term mortality: differences in outcome between acute coronary syndrome and stable angina pectoris.

de Jager TAJ, Dulfer K, Radhoe S, Bergmann MJ, Daemen J, van Domburg RT, Lenzen MJ, Utens EMWJ.

Int J Cardiol. 2018 Jan 1;250:43-48. doi: 10.1016/j.ijcard.2017.10.005. Epub 2017 Oct 6.

PMID:
28992998
20.

The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis - Intravascular Ultrasound (ATHEROREMO-IVUS) study.

de Boer S, Baran Y, Garcia-Garcia HM, Eskin I, Lenzen MJ, Kleber ME, Regar E, de Jaegere PJ, Ligthart JM, van Geuns RJ, Lehtimäki T, Laaksonen R, Boersma E, Marz W, Halperin E, Serruys PW, Koenig W.

EuroIntervention. 2018 Jun 20;14(2):194-203. doi: 10.4244/EIJ-D-17-00180.

21.

Feelings of being disabled as a prognostic factor for mortality in men and women post-PCI up to 12years.

Bergmann MJ, Utens EMWJ, de Jager TAJ, Radhoe SP, Daemen J, Lenzen MJ, van Domburg RT, Dulfer K.

Int J Cardiol. 2017 Dec 15;249:107-111. doi: 10.1016/j.ijcard.2017.09.026. Epub 2017 Sep 14.

PMID:
28923550
22.

Body Mass Index Is Associated With Microvascular Endothelial Dysfunction in Patients With Treated Metabolic Risk Factors and Suspected Coronary Artery Disease.

van der Heijden DJ, van Leeuwen MAH, Janssens GN, Lenzen MJ, van de Ven PM, Eringa EC, van Royen N.

J Am Heart Assoc. 2017 Sep 14;6(9). pii: e006082. doi: 10.1161/JAHA.117.006082.

23.

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P; ESC Scientific Document Group.

Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393. No abstract available.

PMID:
28886621
24.

Development and validation of a risk model for long-term mortality after percutaneous coronary intervention: The IDEA-BIO Study.

van Boven N, van Domburg RT, Kardys I, Umans VA, Akkerhuis KM, Lenzen MJ, Valgimigli M, Daemen J, Zijlstra F, Boersma E, van Geuns RJ.

Catheter Cardiovasc Interv. 2018 Mar 1;91(4):686-695. doi: 10.1002/ccd.27182. Epub 2017 Jul 14.

PMID:
28707322
25.

Proprotein convertase subtilisin/kexin 9 inhibition in patients with familial hypercholesterolemia: Initial clinical experience.

Galema-Boers AMH, Lenzen MJ, Sijbrands EJ, Roeters van Lennep JE.

J Clin Lipidol. 2017 May - Jun;11(3):674-681. doi: 10.1016/j.jacl.2017.02.014. Epub 2017 Mar 7.

PMID:
28506389
26.

First-Line Support by Intra-Aortic Balloon Pump in Non-Ischaemic Cardiogenic Shock in the Era of Modern Ventricular Assist Devices.

den Uil CA, Galli G, Jewbali LS, Caliskan K, Manintveld OC, Brugts JJ, van Mieghem NM, Lenzen MJ, Boersma E, Constantinescu AA.

Cardiology. 2017;138(1):1-8. doi: 10.1159/000471846. Epub 2017 May 13.

27.

The long-term effect of transradial coronary catheterisation on upper limb function.

van Leeuwen MA, van der Heijden DJ, Hermie J, Lenzen MJ, Selles RW, Ritt MJ, Kiemeneij F, Zijlstra F, Van Mieghem NM, van Royen N.

EuroIntervention. 2017 Feb 20;12(14):1766-1772. doi: 10.4244/EIJ-D-15-00395.

28.

Pulsatile iVAC 2L circulatory support in high-risk percutaneous coronary intervention.

den Uil CA, Daemen J, Lenzen MJ, Maugenest AM, Joziasse L, van Geuns RJ, Van Mieghem NM.

EuroIntervention. 2017 Feb 20;12(14):1689-1696. doi: 10.4244/EIJ-D-16-00371.

29.

Expanded clinical use of everolimus eluting bioresorbable vascular scaffolds for treatment of coronary artery disease.

Diletti R, Ishibashi Y, Felix C, Onuma Y, Nakatani S, van Mieghem NM, Regar E, Valgimigli M, de Jaegere PP, van Ditzhuijzen N, Fam JM, Ligthart JMR, Lenzen MJ, Serruys PW, Zijlstra F, Jan van Geuns R.

Catheter Cardiovasc Interv. 2017 Jul;90(1):58-69. doi: 10.1002/ccd.26832. Epub 2016 Nov 29.

PMID:
27896897
30.

Sex differences in plaque characteristics by intravascular imaging in patients with coronary artery disease.

Ten Haaf ME, Rijndertse M, Cheng JM, de Boer SP, Garcia-Garcia HM, van Geuns RM, Regar E, Lenzen MJ, Appelman Y, Boersma E.

EuroIntervention. 2017 Jun 20;13(3):320-328. doi: 10.4244/EIJ-D-16-00361.

31.

Endothelial dysfunction and the occurrence of radial artery spasm during transradial coronary procedures: the ACRA-Spasm study.

van der Heijden D, van Leeuwen MA, Janssens GN, Hermie J, Lenzen MJ, Ritt MJ, van de Ven PM, Kiemeneij F, van Royen N.

EuroIntervention. 2016 Nov 20;12(10):1263-1270. doi: 10.4244/EIJV12I10A207.

32.

The association between subjective health status and 14-year mortality in post-PCI patients.

de Jager TA, Dulfer K, Pieters K, Utens EM, Daemen J, Lenzen MJ, van Domburg RT.

Int J Cardiol. 2017 Feb 15;229:108-112. doi: 10.1016/j.ijcard.2016.11.218. Epub 2016 Nov 9.

PMID:
27865661
33.

Get the Picture: A Pilot Feasibility Study of Telemedical Wound Assessment Using a Mobile Phone in Cardiology Patients.

de Heide J, Vroegh CJ, Szili Torok T, Gobbens RJ, Zijlstra F, Takens-Lameijer M, Lenzen MJ, Yap SC, Scholte Op Reimer WJ.

J Cardiovasc Nurs. 2017 Mar/Apr;32(2):E9-E15. doi: 10.1097/JCN.0000000000000377.

PMID:
27811584
34.

Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.

Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, Lenzen MJ, Simsek C, de Boer SP, Van Mieghem NM, Regar E, de Jaegere PP, Akkerhuis KM, Ligthart JM, Zijlstra F, Serruys PW, Boersma E.

EuroIntervention. 2016 Aug 20;12(6):734-9. doi: 10.4244/EIJV12I6A118.

35.

The PulseCath iVAC 2L left ventricular assist device: conversion to a percutaneous transfemoral approach.

Van Mieghem NM, Daemen J, Lenzen MJ, Zandstra R, Malkin O, van Geuns RJ.

EuroIntervention. 2015 Nov;11(7):835-9. doi: 10.4244/EIJV11I7A168.

36.

Smoking in Relation to Coronary Atherosclerotic Plaque Burden, Volume and Composition on Intravascular Ultrasound.

Buljubasic N, Akkerhuis KM, de Boer SP, Cheng JM, Garcia-Garcia HM, Lenzen MJ, Oemrawsingh RM, Battes LC, Rijndertse M, Regar E, Serruys PW, van Geuns RJ, Boersma E, Kardys I.

PLoS One. 2015 Oct 22;10(10):e0141093. doi: 10.1371/journal.pone.0141093. eCollection 2015.

37.

The effect of transradial coronary catheterization on upper limb function.

van Leeuwen MA, van Mieghem NM, Lenzen MJ, Selles RW, Hoefkens MF, Zijlstra F, van Royen N.

JACC Cardiovasc Interv. 2015 Apr 20;8(4):515-23. doi: 10.1016/j.jcin.2014.10.025. Epub 2015 Mar 26.

38.

Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease.

Oemrawsingh RM, Cheng JM, García-García HM, van Geuns RJ, de Boer SP, Simsek C, Kardys I, Lenzen MJ, van Domburg RT, Regar E, Serruys PW, Akkerhuis KM, Boersma E; ATHEROREMO-NIRS Investigators.

J Am Coll Cardiol. 2014 Dec 16;64(23):2510-8. doi: 10.1016/j.jacc.2014.07.998.

39.

[10 years of transcatheter aortic valve implantation: an overview of the clinical applicability and findings].

de Ronde-Tillmans MJ, Lenzen MJ, Abawi M, Van Mieghem NM, Zijlstra F, De Jaegere PP.

Ned Tijdschr Geneeskd. 2014;158:A7768. Review. Dutch.

PMID:
25308222
40.

Circulating chemokines in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and cardiovascular outcome.

Cheng JM, Oemrawsingh RM, Akkerhuis KM, Garcia-Garcia HM, de Boer SP, Battes LC, Buljubasic N, Lenzen MJ, de Jaegere PP, van Geuns RJ, Serruys PW, Kardys I, Boersma E.

Biomarkers. 2014 Nov;19(7):611-9. doi: 10.3109/1354750X.2014.957725. Epub 2014 Sep 8.

PMID:
25196123
41.

Excess mortality in women compared to men after PCI in STEMI: an analysis of 11,931 patients during 2000-2009.

de Boer SP, Roos-Hesselink JW, van Leeuwen MA, Lenzen MJ, van Geuns RJ, Regar E, van Mieghem NM, van Domburg R, Zijlstra F, Serruys PW, Boersma E.

Int J Cardiol. 2014 Sep 20;176(2):456-63. doi: 10.1016/j.ijcard.2014.07.091. Epub 2014 Aug 1.

PMID:
25127966
42.

Predicting non-adherence in patients with familial hypercholesterolemia.

Galema-Boers JM, Lenzen MJ, van Domburg RT, Roeters van Lennep J, van Bruchem-van de Scheur GG, Sijbrands EJ, Langendonk JG.

Eur J Clin Pharmacol. 2014 Apr;70(4):391-7. doi: 10.1007/s00228-013-1640-3. Epub 2014 Jan 22.

PMID:
24449092
43.

Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.

Diletti R, Karanasos A, Muramatsu T, Nakatani S, Van Mieghem NM, Onuma Y, Nauta ST, Ishibashi Y, Lenzen MJ, Ligthart J, Schultz C, Regar E, de Jaegere PP, Serruys PW, Zijlstra F, van Geuns RJ.

Eur Heart J. 2014 Mar;35(12):777-86. doi: 10.1093/eurheartj/eht546. Epub 2014 Jan 6.

PMID:
24394380
44.

Trial participation as a determinant of clinical outcome: differences between trial-participants and Every Day Clinical Care patients in the field of interventional cardiology.

de Boer SP, van Leeuwen MA, Cheng JM, Oemrawsingh RM, van Geuns RJ, Serruys PW, Boersma E, Lenzen MJ.

Int J Cardiol. 2013 Nov 15;169(4):305-10. doi: 10.1016/j.ijcard.2013.09.011. Epub 2013 Oct 5.

PMID:
24144926
45.

Determinants of high cardiovascular risk in relation to plaque-composition of a non-culprit coronary segment visualized by near-infrared spectroscopy in patients undergoing percutaneous coronary intervention.

de Boer SP, Brugaletta S, Garcia-Garcia HM, Simsek C, Heo JH, Lenzen MJ, Schultz C, Regar E, Zijlstra F, Boersma E, Serruys PW.

Eur Heart J. 2014 Feb;35(5):282-9. doi: 10.1093/eurheartj/eht378. Epub 2013 Sep 12.

PMID:
24037276
46.

Life-years gained by smoking cessation after percutaneous coronary intervention.

de Boer SP, Serruys PW, Valstar G, Lenzen MJ, de Jaegere PJ, Zijlstra F, Boersma E, van Domburg RT; interventional cardiologists of the Thoraxcentre 1980 to 1985.

Am J Cardiol. 2013 Nov 1;112(9):1311-4. doi: 10.1016/j.amjcard.2013.05.075. Epub 2013 Jul 25.

PMID:
23891246
47.

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D.

Eur Heart J. 2012 Oct;33(20):2569-619. doi: 10.1093/eurheartj/ehs215. Epub 2012 Aug 24. No abstract available.

PMID:
22922416
48.

Primary PCI during off-hours is not related to increased mortality.

de Boer SP, Oemrawsingh RM, Lenzen MJ, van Mieghem NM, Schultz C, Akkerhuis KM, van Leeuwen MA, Zijlstra F, van Domburg RT, Serruys PW, Boersma E.

Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):33-9. doi: 10.1177/2048872612441581.

49.

Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants.

de Boer SP, Lenzen MJ, Oemrawsingh RM, Simsek C, Duckers HJ, van der Giessen WJ, Serruys PW, Boersma E.

Eur Heart J. 2011 Sep;32(17):2161-7. doi: 10.1093/eurheartj/ehr126. Epub 2011 May 12.

PMID:
21565848
50.

Health-related quality of life predicts long-term survival in patients with peripheral artery disease.

Issa SM, Hoeks SE, Scholte op Reimer WJ, Van Gestel YR, Lenzen MJ, Verhagen HJ, Pedersen SS, Poldermans D.

Vasc Med. 2010 Jun;15(3):163-9. doi: 10.1177/1358863X10364208.

PMID:
20483986

Supplemental Content

Loading ...
Support Center